SEARCH

SEARCH BY CITATION

References

  • 1
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 285: 24862497.
  • 2
    Bouchard, C. (1995) Genetics and the metabolic syndrome. Int J Obes. 19(Suppl 1): S52S59.
  • 3
    Bujalska, I. J., Kumar, S., Stewart, P. M. (1997) Does central obesity reflect “Cushing's disease of the omentum”? Lancet. 349: 12101213.
  • 4
    Wajchenberg, B. L., Bosco, A., Marone, M. M., et al. (1995) Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab. 80: 27912794.
  • 5
    Masuzaki, H., Paterson, J., Shinyama, H., et al. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 21662170.
  • 6
    Gelernter-Yaniv, L., Feng, N., Sebring, N. G., Hochberg, Z., Yanovski, J. A. (2003) Associations between a polymorphism in the 11 beta hydroxysteroid dehydrogenase type I gene and body composition. Int J Obes Relat Metab Disord. 27: 983986.
  • 7
    Caramelli, E., Strippoli, P., Di Giacomi, T., Tietz, C., Carinci, P., Pasquali, R. (2001) Lack of mutations of type 1 11beta-hydroxysteroid dehydrogenase gene in patients with abdominal obesity. Endocr Res. 27: 4761.
  • 8
    Jamieson, A., Wallace, A. M., Andrew, R., et al. (1999) Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1. J Clin Endocrinol Metab. 84: 35703574.
  • 9
    Draper, N., Walker, E. A., Bujalska, I. J., et al. (2003) Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet. 34: 434439.
  • 10
    Berthier, M. T., Couillard, C., PruD'homme, D., et al. (2001) Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men. Obes Res. 9: 668675.